| Differentiation of intestinal and hepatic cytochrome P450 3A activity with use of midazolam as an in vivo probe: effect of ketoconazole SM Tsunoda, RL Velez, LL von Moltke, DJ Greenblatt Clinical pharmacology & therapeutics 66 (5), 461-471, 1999 | 310 | 1999 |
| Dietary effects on drug metabolism and transport RZ Harris, GR Jang, S Tsunoda Clinical pharmacokinetics 42, 1071-1088, 2003 | 298 | 2003 |
| The use of therapeutic drug monitoring to optimise immunosuppressive therapy SM Tsunoda, FT Aweeka Clinical pharmacokinetics 30, 107-140, 1996 | 86 | 1996 |
| A review of interleukin‐2 receptor antagonists in solid organ transplantation JL Berard, RL Velez, RB Freeman, SM Tsunoda Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 19 (10 …, 1999 | 83 | 1999 |
| Evaluation of In Vivo P-Glycoprotein Phenotyping Probes: A Need for Validation JD Ma, SM Tsunoda, JS Bertino, M Trivedi, KK Beale, AN Nafziger Clinical pharmacokinetics 49, 223-237, 2010 | 80 | 2010 |
| Red wine decreases cyclosporine bioavailability SM Tsunoda, RZ Harris, U Christians, RL Velez, RB Freeman, LZ Benet, ... Clinical Pharmacology & Therapeutics 70 (5), 462-467, 2001 | 80 | 2001 |
| The effects of menopause and hormone replacement therapies on prednisolone and erythromycin pharmacokinetics RZ Harris, SM Tsunoda, P Mroczkowski, H Wong, LZ Benet Clinical Pharmacology & Therapeutics 59 (4), 429-435, 1996 | 67 | 1996 |
| Limited sampling strategy to predict AUC of the CYP3A phenotyping probe midazolam in adults: application to various assay techniques JS Kim, AN Nafziger, SM Tsunoda, EF Choo, DS Streetman, ... The Journal of Clinical Pharmacology 42 (4), 376-382, 2002 | 62 | 2002 |
| Contribution of the gut microbiome to drug disposition, pharmacokinetic and pharmacodynamic variability SM Tsunoda, C Gonzales, AK Jarmusch, JD Momper, JD Ma Clinical pharmacokinetics 60, 971-984, 2021 | 51 | 2021 |
| Opioid antagonists in the treatment of pruritus from cholestatic liver disease SG Terra, SM Tsunoda Annals of Pharmacotherapy 32 (11), 1228-1230, 1998 | 41 | 1998 |
| Cost minimization of medicare part D prescription drug plan expenditures. RA Patel, HL Lipton, TW Cutler, AR Smith, SM Tsunoda, MR Stebbins The American journal of managed care 15 (8), 545-553, 2009 | 34 | 2009 |
| Drug concentration monitoring of immunosuppressive agents: focus on tacrolimus, mycophenolate mofetil and sirolimus SM Tsunoda, FT Aweeka BioDrugs 14, 355-369, 2000 | 27 | 2000 |
| Chemical proportionality within molecular networks D Petras, AM Caraballo-Rodríguez, AK Jarmusch, C Molina-Santiago, ... Analytical Chemistry 93 (38), 12833-12839, 2021 | 25 | 2021 |
| Preliminary evaluation of progestins as inducers of cytochrome P450 3A4 activity in postmenopausal women SM Tsunoda, RZ Harris, PJ Mroczkowski, LZ Benet The Journal of Clinical Pharmacology 38 (12), 1137-1143, 1998 | 24 | 1998 |
| Effect of renal disease and hemodialysis on foscarnet pharmacokinetics and dosing recommendations FT Aweeka, MA Jacobson, S Martin-Munley, A Hedman, P Schoenfeld, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 20 (4), 350-357, 1999 | 23 | 1999 |
| Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry JPS Sawhney, VA Kothiwale, V Bisne, R Durgaprasad, P Jadhav, ... Indian heart journal 70 (6), 828-835, 2018 | 22 | 2018 |
| Evaluation of proposed in vivo probe substrates and inhibitors for phenotyping transporter activity in humans JD Momper, SM Tsunoda, JD Ma The Journal of Clinical Pharmacology 56, S82-S98, 2016 | 21 | 2016 |
| Enhanced characterization of drug metabolism and the influence of the intestinal microbiome: a pharmacokinetic, microbiome, and untargeted metabolomics study AK Jarmusch, A Vrbanac, JD Momper, JD Ma, M Alhaja, M Liyanage, ... Clinical and Translational Science 13 (5), 972-984, 2020 | 20 | 2020 |
| Initial development toward non-invasive drug monitoring via untargeted mass spectrometric analysis of human skin AK Jarmusch, EO Elijah, F Vargas, A Bouslimani, RR da Silva, M Ernst, ... Analytical chemistry 91 (13), 8062-8069, 2019 | 20 | 2019 |
| Comparison of international normalized ratio audit parameters in patients enrolled in GARFIELD‐AF and treated with vitamin K antagonists DA Fitzmaurice, G Accetta, S Haas, G Kayani, H Lucas Luciardi, ... British journal of haematology 174 (4), 610-623, 2016 | 20 | 2016 |
